Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa and Pyridostigmine for Orthostatic Hypotension
NCT01370512Phase 2Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Nov 2011
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of droxidopa, pyridostigmine in orthostatic hypotension (OH), sponsored by Mayo Clinic. Started Nov 2011; status: enrolling by invitation.
02
Drugs
droxidopapyridostigmine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT01370512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370512.